Dr. Lauren J Akers DO Pediatric Hematologist-Oncologist

Dr. Lauren Akers is a pediatric hematologist-oncologist in Fort Worth, Texas. She is affiliated with multiple hospitals in the area, including Cook Children's Medical Center and Texas Health Harris Methodist Hospital Fort Worth. She received her medical degree from Nova Southeastern University College of Osteopathic Medicine and has been in practice for 12 years. Dr. Akers accepts several types of health insurance, listed below. She is one of 14 doctors at Cook Children's Medical Center and one of 12 at Texas Health Harris Methodist Hospital Fort Worth who specialize in Pediatric Hematology-Oncology.

Are you Dr. Lauren Akers? Claim your profile to make edits or add details. Edit Profile

Office Location

See Contact Information

Specialty & Clinical Interests

Pediatric Hematologist-Oncologist: General Pediatric Hematology & Oncology

Clinical Interests: Pediatric Oncology

Hospital Affiliation

Cook Children's Medical Center
Ranked #38 in Pediatrics: Cancer

Texas Health Harris Methodist Hospital Fort Worth

Education & Medical Training

Austin Medical Education Program - Seton Health
Residency, Pediatrics, 2002 - 2005

University of Texas at Houston
Fellowship, Pediatric Hematology/Oncology, 2005 - 2008

Nova Southeastern University College of Osteopathic Medicine
Class of 2002

Certifications & Licensure

American Board of Pediatrics
Certified 9 years in Pediatrics

American Board of Pediatrics
Certified 5 years in Pediatric Hematology-Oncology

TX State Medical License

Publications & Presentations

Notch activation inhibits AML growth and survival: a potential therapeutic approach.
Kannan, S.,Sutphin, R. M.,Hall, M. G.,Golfman, L. S.,Fang, W.,Nolo, R. M.,Akers, L. J.,Hammitt, R. A.,McMurray, J. S.,Kornblau, S. M.,Melnick, A. M.,Figueroa, M. E.,Zweidler-McKay, P. A.

Targeting glycolysis in leukemia: A novel inhibitor 3-BrOP in combination with rapamycin.
Akers, L. J.,Fang, W.,Levy, A. G.,Franklin, A. R.,Huang, P.,Zweidler-McKay, P. A.

The combination of the novel glycolysis inhibitor 3-BrOP and rapamycin is effective against neuroblastoma.
Levy, A.G., Zage, P.E., Akers, L.J., Ghisoli, M.L., Chen, Z., Fang, W., Kannan, S., Graham, T., Zeng, L., Franklin, A.R., Huang, P., Zweidler-McKay, P.A.

Insurances Accepted

  • Aetna Choice POS II
  • Aetna HMO
  • Anthem Blue Access PPO
  • Anthem Blue Preferred HMO
  • Anthem Blue Preferred Plus POS
  • BCBS Blue Card PPO
  • BCBS Illinois PPO
  • BCBS Texas BlueChoice
  • CIGNA Open Access
  • Cofinity PPO
  • First Health PPO
  • Great West PPO
  • Humana ChoiceCare Network PPO
  • Multiplan PHCS PPO
  • Multiplan PPO
  • United Healthcare - Direct Choice Plus POS
  • United Healthcare - Direct Options PPO
  • WEA Trust Preferred Provider Plan - Trust Pref
Find More Doctors
Doctor Finder

Our Doctor Finder includes most U.S. physicians. Doctors are not ranked, learn more.

Browse Doctors by



Search all Doctors

Profiles by Doximity

Your Message Has Been Submitted

As part of our research on the correction you submitted, you may be contacted at the email address provided.

Sorry, Your Message Could Not Be Submitted

Please try again later, or E-mail your message to doctors@usnews.com and include the Web address (URL) of the page that contains incorrect information.